Network News

At the request of Heidelberg University Hospital, the Ministry of Social Affairs, Health and Integration has confirmed that the merger of the two university hospitals in Heidelberg and Mannheim is deemed necessary to improve hospital care and that the merger does not conflict with any other competition law regulations. Press release from the Ministry of […]

The partnership combines VERAXA’s proprietary ADC technology with OmniAb’s antibody discovery technology for novel therapies targeting solid tumors. ZURICH, SWITZERLAND, May 5, 2025 — VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today a co-discovery alliance with OmniAb, Inc. (NASDAQ: […]

Professor Dr. Gerd Auffarth continues to be one of the world’s leading ophthalmologists, according to “The Ophthalmologist”. The journal has now published its “Power List 2025” of the most influential representatives of the field. The Medical Director of the Eye Clinic at Heidelberg University Hospital (UKHD) has now been named on the list for the […]

The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company focused on the development of a comprehensive pipeline of next-generation cancer therapies. ZURICH, SWITZERLAND, and BROOKLYN, NEW YORK, USA, April 23, 2025 — VERAXA Biotech AG(“VERAXA” or the “Company”), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands […]

HEIDELBERG, Germany, April 15, 2025 – NEC Laboratories Europe and Data-Driven.AI are working together to enhance medical laboratory diagnosis and increase the effectiveness of preventive health measures and early clinical intervention to improve the well-being of patients. If detected early, many illnesses and diseases can be managed or resolved without serious complications. However, by the time recognizable symptoms present themselves, […]

From April 28 to May 24, you can once again buy and give flower creations throughout Germany for the benefit of children and young people with cancer. With its campaign “Blumen schenken. Hoffnung spenden.” (Give flowers. Spread hope.) the Hopp Children’s Cancer Center Heidelberg (KiTZ) wants to draw attention to the urgently needed research for […]

GSK plc (LSE/NYSE: GSK) today announced the authorisation of Blenrep by the Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Blenrep is approved for the treatment of adults with multiple myeloma in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) in […]

Heidelberg, Germany, April 7th, 2025. BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of its XBridge Program, a fast-track initiative designed to support U.S.-based biomedical researchers impacted by the current NIH funding gaps, hiring freezes, and grant terminations. The program offers a pathway for affected principal investigators in all […]

The 2023/24 Meyenburg Prize, endowed with 50,000 euros, goes to Michel Sadelain of Columbia University, New York. The physician and immunologist is considered one of the fathers of CAR-T cell therapy. This cellular immunotherapy can be used to effectively treat certain blood cancers, even in advanced stages. The Meyenburg Prize will be awarded on Wednesday, […]